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Abstract: In Bangladesh, although some research on health expectancy exists, life 
expectancies with and without hypertension (HTN) have never been computed. We 
examined gender differences in the prevalence of hypertension and Hypertension-Free 
Life Expectancy (HFLE) in Bangladesh. We used data from a nationally representative 
survey of 7,864 people aged 35 and older. We classified an individual as having HTN 
if s/he had blood pressure levels ≥140 mmHg systolic blood pressure or ≥90 mmHg 
diastolic blood pressure, or s/he was at the time on antihypertensive medication. The 
Sullivan method was employed to compute HFLE. We found that women have HTN in 
significantly higher percentages (32% of women vs. 19% of men), and the prevalence 
of HTN increases as age increases for both men and women. Among individuals with 
HTN, individuals unaware of HTN make up the largest group, followed by those 
with uncontrolled HTN, controlled HTN, and those who are aware of HTN but not in 
treatment. Compared with men, women could expect shorter HFLE at all ages, in terms 
of both number and proportion of years. To increase HFLE as well as quality of life 
and to prevent and control HTN in general and unawareness of HTN and uncontrolled 
HTN in particular, special care and attention should be given to women and older 
adults. The findings shed important light on the role of HTN in lowering the quality of 
life in Bangladesh.
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Life expectancy (LE) is increasing all over the world (Riley, 2005), but it does not 
mean a healthier population (Crimmins, Hayward, and Saito, 1994; Jagger, Gillies, 
Moscone et al., 2008; Robine, Jagger, Mathers et al., 2003) . When people live longer, 
quality of life becomes a central issue (Liu, Chen, Song et al., 2009), and the health 
expectancy of a population can be computed to provide an estimate of its quality of 
life. Health expectancy measures were developed to add a quality-of-life aspect to life 
expectancy measures (Sanders, 1964). They are very useful in monitoring population 
health (Saito, Qiao, and Jitapunkul, 2003; Saito, Robine, and Crimmins, 2014; 
Stiefel, Perla, and Zell, 2010) and should be linked to population and health policy-
making in the new era (Saito, Qiao, and Jitapunkul, 2003). Health expectancy data are 
invaluable for predicting future needs, evaluating health programs, identifying trends 
and inequalities in health, and planning health, disability and social services, long term 
care, pensions, etc.
In Bangladesh, some research on health expectancy exists, which includes 
information on disability-free life expectancy and healthy life expectancy for people 
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of all ages and adults aged 60 years and older as well as information on healthy 
life expectancy for people aged 15 years and above. For example, in Bangladesh 
as a whole, despite having longer LE, elderly women have a greater prevalence 
of disability and shorter disability-free life expectancy than elderly men (Tareque, 
Begum, and Saito, 2013). Clear inequalities in LE, disability-free life expectancy 
and LE with disability between rural and urban areas are reported. Urban males and 
females, respectively, have a longer disability-free life expectancy and shorter LE with 
disability both in number and proportion when compared to rural males and females 
(Islam, Tareque, Mondal et al., 2017). Healthy life expectancy declines significantly 
as age increases in the Rajshahi district of Bangladesh (Tareque, Islam, Kawahara 
et al., 2015). Men expected fewer life years spent in good health but a much larger 
proportion of expected life in good health than did women in Bangladesh in 1996 
and 2002 (Tareque, Saito, and Kawahara, 2015). However, life expectancies with and 
without hypertension (HTN) have never been computed in Bangladesh.
Raised or high blood pressure acts as one of the contributing and intermediate risk 
factors for developing coronary heart disease, stroke, and kidney disease. High blood 
pressure in adulthood is reported to be associated with reduced LE and more years 
of expected life with cardiovascular disease, and in the United States, it affects both 
men and women similarly (Franco, Peeters, Bonneux et al., 2005). The LE benefits 
of antihypertensive treatment were examined in a study for the United States (Sesso, 
Chen, L’Italien et al., 2003). Successful blood pressure lowering in hypertensive 
patients and those with additional cardiovascular disease risk factors such as diabetes 
or current smoking was reported to have the potential to provide substantial gains in 
LE. The study revealed that gains in LE occurred with even modest reductions in blood 
pressure (Sesso, Chen, L’Italien et al., 2003).
A number of studies have been devoted to gender differences in health, mortality, 
and health expectancy (Doblhammer and Hoffmann, 2010; Knodel and Ofstedal, 2003; 
Mishra, Roy, and Retherford, 2004; Oksuzyan, Juel, Vaupel et al., 2008; Tareque, 
Begum, and Saito, 2013), which have been of longstanding interest to researchers. 
Gender differences in HTN as well as Hypertension-Free Life Expectancy (HFLE) 
are also areas of interest, particularly in Bangladesh where women are highly 
disadvantaged compared with men. In Bangladesh, HTN is reported to be higher 
among women and the older population than among their counterparts (National 
Institute of Population Research and Training (NIPORT), Mitra and Associates, and 
ICF International, 2013; Saquib, Saquib, Ahmed et al., 2012; Tareque, Koshio, Tiedt 
et al., 2015). Though there were fluctuations in male and female LE at age 35 and 
over until 2005, since 2006 female LE at every age has been consistently longer than 
that of males in Bangladesh (Bangladesh Bureau of Statistics (BBS), 2011). In 2011, 
female and male LE at age 35 were, respectively, 40.08 and 38.92 years (World Health 
Organization, 2014). Whether greater LE implies better health and longer HFLE for 
women is a critical question in Bangladesh. The current study thus examines gender 
differences in HTN prevalence and in HFLE in Bangladesh.
2 Materials and Methods
2.1 Data
This study utilized data from a nationally representative sample survey, the 2011 
Bangladesh Demographic and Health Survey (BDHS). The 2011 BDHS is the sixth 
Demographic and Health Survey undertaken in Bangladesh. The sampling design, 
questionnaires, and data collection procedures of the 2011 BDHS are described 
elsewhere in detail (National Institute of Population Research and Training (NIPORT), 
Mitra and Associates, and ICF International, 2013). The 2011 BDHS is the first 
survey that collected blood pressure measurements for people aged 35 years and 
over. It collected data from individuals residing in non-institutional dwelling units in 
Bangladesh and is based on a two-stage stratified sample of households. Based on the 
sampling design, a total of 17,964 households were selected, 17,511 of which were 
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found to be occupied. Interviews were successfully completed in 17,141 households, 
or 98% of all the occupied households. In one-third of households in the 2011 BDHS, 
all men and women aged 35 and older (4,524 men and 4,311 women) were selected 
for blood pressure measurements. We selected those who gave their full consent to 
participate in blood pressure measurements, and consequently, the final study sample 
size dropped to 7,864 (3,895 men and 3,969 women). 
The participants who were dropped from the whole analysis due to non-consent 
did not differ by age from those included in the analysis. The dropped participants’ 
mean age was 51.27 years whereas the included participants’ mean age was 51.38 
years (difference 0.11 years, p < 0.80). However, the dropped participants differed 
significantly from the included participants by sex, marital status, education 
level, and place of residence. Thirty-five percent of the dropped participants were 
female, whereas half of the included participants were female (p < 0.01). Eighty-
one percent of the dropped participants were currently married, whereas 84% of the 
included participants were currently married (p < 0.05). Forty percent of the dropped 
participants were illiterate, whereas 45% of the included participants were illiterate (p 
< 0.01). Fifty-eight percent of the dropped participants came from rural areas, whereas 
67% of the included participants came from rural areas (p < 0.01).
2.2 HTN Measurements
The 2011 BDHS used the Life Source UA-767 Plus blood pressure monitor model 
to measure blood pressure. This model is one of the blood pressure monitors 
recommended for use by World Health Organization. Three measurements of both 
systolic blood pressure (SBP) and diastolic blood pressure (DBP) were taken during 
the survey at approximately 10-minute intervals. Only the average of the second and 
third measurements was available in the data set we used to report respondents’ blood 
pressure values. In addition, each respondent was asked whether s/he had ever been 
told by a doctor or nurse that s/he had high blood pressure. Each respondent was 
also asked whether s/he was currently taking antihypertensive medication to lower 
their blood pressure. An individual was considered to have HTN if s/he had blood 
pressure levels ≥140 mmHg SBP or ≥90 mmHg DBP, or s/he was currently taking 
antihypertensive medication to lower their blood pressure. Based on the blood pressure 
measurements, medications, and doctor or nurse diagnoses of respondents’ high blood 
pressure, we classified HTN into four types: (i) unaware of HTN, (ii) aware of HTN 
but not in treatment, (iii) controlled HTN, and (iv) uncontrolled HTN. An individual 
was considered to be unaware of HTN if s/he had blood pressure levels ≥140 mmHg 
SBP or ≥90 mmHg DBP, was not taking any medication, and had never been told by 
a doctor or nurse that s/he had high blood pressure. An individual was considered to 
be aware of HTN but not in treatment if s/he had blood pressure levels ≥ 140 mmHg 
SBP or ≥ 90 mmHg DBP, was not taking any medication, but had been told by a doctor 
or nurse that s/he had high blood pressure. An individual was considered to have 
controlled HTN if s/he had blood pressure levels < 140 mmHg SBP or < 90 mmHg 
DBP, was taking medication, and had been told by a doctor or nurse that s/he had high 
blood pressure. An individual was considered to have uncontrolled HTN if s/he had 
blood pressure levels ≥ 140 mmHg SBP or ≥ 90 mmHg DBP, was taking medication, 
and had been told by a doctor or nurse that s/he had high blood pressure.
2.3 Estimation of HFLE
The Sullivan method (Sullivan, 1971) was employed to compute HFLE for the year 
2011 for Bangladesh. It partitions total LE into LE with different types of HTN and 
HFLE based on the prevalence of HTN within a representative sample at a single point 
in time. The Sullivan method requires two types of data: a standard period life table 
where mortality information of a population can be found, and the prevalence of HTN 
for that population. The life table for Bangladesh for the year 2011 was obtained from 
the World Health Organization (World Health Organization, 2014). The proportion of 
the Bangladeshi population with HTN for the year 2011 was obtained from the 2011 
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BDHS. By combining these data, we estimated HFLE for the study population. See 
the manual (Jagger, Cox, Le Roy et al., 2006) for more details on the computation of 
HFLE and confidence intervals using the Sullivan method. To take into account the 
population living in institutions who were excluded from the 2011 BDHS, we assumed 
that the prevalence of HTN outside and within institutions does not differ.
2.4 Analysis Plan
We examined the prevalence of HTN by age and sex first. We used STATA/MP version 
13.0 (StataCorp LP, College Station, Texas, USA) to perform a two-sided test for 
equality of proportions in HTN. Sample weights were applied to accommodate the 
complex survey design. Estimates of HFLE and LE with different types of HTN were 
then obtained using the Sullivan method. Finally, the estimates of HFLE and LE with 
different types of HTN were plotted in graph form.
3 Results
Table 1 shows gender differences for different types of HTN prevalence in Bangladesh 
in 2011. A significantly greater percentage of women have HTN than men (32% of 
women vs. 19% of men). Among all individuals with HTN, individuals unaware of 
HTN make up the largest group (56% of men vs. 45% of women), followed by those 
with uncontrolled HTN (20% of men vs. 25% of women), controlled HTN (16% of 
men vs. 20% of women), and those aware of HTN but not in treatment (8% of men vs. 
11% of women) (results not shown).
Table 1. Prevalence of different types of hypertension by age and sex in Bangladesh in 2011
Age
Male      Female      
% % % % %  % % % % %  
HTN UofHTN AofHTNnoTreat CHTN UHTN n HTN UofHTN AofHTNnoTreat CHTN UHTN n
35-39   9.78*   7.89   0.44* 0.51* 0.94* 682 17.79 7.78 2.31 3.94  3.76 810
40-44 14.40*   8.93   1.77 2.05* 1.65* 641 24.99 10.62 2.10 6.46  5.81 721
45-49 15.65* 10.08*   1.01 2.67* 1.89* 592 30.98 15.74 2.23 6.44  6.56 648
50-54 21.12* 11.80   1.48 2.50* 5.34* 626 33.38 12.90 2.21 8.86  9.41 430
55-59 20.10*   8.80*   2.60 2.24* 6.46 304 37.62 17.08 3.80 6.81  9.93 406
60-64 26.02* 10.94†   2.23† 7.31 5.54 314 35.10 16.95 5.41 3.99  8.74 311
65-69 31.25* 12.64*   1.59* 9.91 7.11 253 54.58 28.96 6.00 7.81 11.81 203
70+ 29.75* 17.54   1.80* 3.68* 6.73* 483 50.06 19.41 7.15 7.52 15.99 440
Total 19.31* 10.87*   1.48* 3.11* 3.85* 3895 31.76 14.17 3.38 6.23  7.99 3969
Notes: HTN: Hypertension; UofHTN: Unaware of hypertension; AofHTNnoTreat: Aware of hypertension but no treatment; CHTN: Controlled 
hypertension; UHTN: Uncontrolled hypertension; n: Number of respondents. Levels of significance for percent difference of hypertension between 
male and female: * p < 0.01, † p < 0.05.
At each age, a significantly higher percentage of women have HTN than do men. 
Across all ages, women also have all types of HTN in higher percentages than do men, 
except for controlled HTN for age groups 60–69. In general, the prevalence of all types 
of HTN increases with increasing age. For both men and women, a higher percent of 
older individuals have all types of HTN than do their younger counterparts, except for 
the 70+ years age group. At ages 35–39, 10% of men and 18% of women have HTN, 
whereas at ages 65–69, 31% of men and 55% of women have HTN.
Table 2 presents LE, HFLE, the proportion of expected life without HTN by age and 
sex, and gender differences in LE and HFLE by age in Bangladesh in 2011. At each 
age, women have a longer LE compared with men. Women at age 35 could expect to 
live 40.08 years, which is 1.16 years longer than men. At age 65, women could expect 
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to live 0.32 years (117 days) longer than men. The differences in LE decrease with 
increasing ages.
Table 2. LE, HFLE, and proportion of expected life without hypertension by age and sex in Bangladesh in 2011
Age


















35 38.92 30.69 (30.16, 31.23) 78.87 40.08 25.59 (24.94, 26.24) 63.86 -1.16 5.10*
40 34.29 26.48 (25.95, 27.00) 77.21 35.45 21.71 (21.07, 22.36) 61.25 -1.16 4.76*
45 29.77 22.56 (22.04, 23.08) 75.79 30.90 18.23 (17.60, 18.87) 59.01 -1.13 4.33*
50 25.44 18.85 (18.34, 19.36) 74.09 26.44 15.10 (14.48, 15.72) 57.10 -1.00 3.75*
55 21.35 15.57 (15.07, 16.08) 72.94 22.14 12.16 (11.57, 12.75) 54.92 -0.79 3.41*
60 17.61 12.49 (12.00, 12.97) 70.90 18.18   9.60  (9.03, 10.18) 52.82 -0.57 2.88
65 14.27  9.95  (9.48, 10.43) 69.76 14.59   7.07  (6.51, 7.64) 48.49 -0.32 2.88*
70 11.28  7.92  (7.46, 8.38) 70.25 11.40   5.69  (5.16, 6.23) 49.94 -0.12 2.23*
Notes:  LE: Life expectancy; HFLE: Hypertension-free life expectancy; HTN, Hypertension; CI: Confidence interval.
† Differences are not statistically tested.
§ Differences are statistically tested.
* p < 0.01.
Despite having longer LE, at each age, women could expect shorter HFLE than men 
in terms of both number and proportion of years. At age 35, women could expect 64% 
of their remaining life without HTN (LE: 40.08 years, HFLE: 25.59 years), while men 
could expect 79% of their remaining life without HTN (LE: 38.92 years, HFLE: 30.69 
years). At age 65, women and men, respectively, could expect 49% and 70% of their 
remaining life without HTN. Men at age 65 could expect a much greater proportion of 
their remaining life without HTN than women at age 35. 
Although women at age 35 could expect to live 1.16 years longer than men, they 
could expect 5.10 years shorter HFLE than could men. At age 65, women could expect 
117 days longer LE but 2.88 years shorter HFLE than men. The differences in HFLE 
also decrease with increasing ages.
Table 3 displays the decomposition of LE with HTN into LE with four types of 
HTN by age and sex in Bangladesh in 2011. Across ages, and in terms of both number 
and proportion of years, men and women who were unaware of HTN could expect 
the longest LE with HTN, followed by men and women with uncontrolled HTN, 
controlled HTN, and those with awareness of HTN but who were not in treatment. At 
age 35, a woman and a man, respectively, could expect 6.44 and 4.46 years of life with 
unawareness of HTN, 3.79 and 1.74 years of life with uncontrolled HTN, 2.62 and 1.40 
years of life with controlled HTN, and 1.64 and 0.62 years of life with awareness of 
HTN but not receiving treatment. At age 65, a woman and a man, respectively, could 
expect 3.28 and 2.28 years of life with unawareness of HTN, 2.14 and 0.98 years of 
life with uncontrolled HTN, 1.11 and 0.81 years of life with controlled HTN, and 
0.99 and 0.25 years of life with awareness of HTN but not receiving treatment. The 
proportion of LE with HTN increases as age increases for both men and women, but 
the proportion of LE with HTN for men at age 65 is lower than the proportion of LE 
with HTN for women at age 35.
Figure 1 displays HFLE and LE with four types of HTN by age and sex. Here, 
each bar represents LE, which comprises HFLE and LE with four types of HTN. At 
each age, for both men and women, HFLE accounts for the largest proportion of LE, 
followed by LE with unawareness of hypertension, LE with uncontrolled hypertension, 
LE with controlled hypertension, and LE with awareness of hypertension but no 
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treatment. Compared with men, women at all ages are clearly found to expect longer 
LE, shorter HFLE, and longer LE with all types of HTN.



















Male LE with HTN 8.22 21.13 6.59 25.91 4.31 30.24
LE with types of HTN
LEwUofHTN 4.46 11.47 3.31 13.00 2.28 15.95
LEwAofHTNnoTreat 0.62 1.60 0.49 1.93 0.25 1.73
LEwCHTN 1.40 3.59 1.20 4.72 0.81 5.70
LEwUHTN 1.74 4.46 1.59 6.27 0.98 6.85
Female LE with HTN 14.49 36.14 11.34 42.90 7.51 51.52
LE with types of HTN
LEwUofHTN 6.44 16.06 4.97 18.80 3.28 22.47
LEwAofHTNnoTreat 1.64 4.08 1.37 5.17 0.99 6.78
LEwCHTN 2.62 6.55 1.88 7.10 1.11 7.61
 LEwUHTN 3.79 9.46 3.13 11.84 2.14 14.65
Notes: HTN: Hypertension; Prop: Proportion of life with types of HTN; LE: Life expectancy; LEwUofHTN: LE with unawareness of hypertension; 
LEwAofHTNnoTreat: LE with awareness of hypertension but no treatment; LEwCHTN: LE with controlled hypertension; LEwUHTN: LE with 
uncontrolled hypertension.
Figure 1. HFLE and LE with different types of hypertension by age and sex in Bangladesh in 2011
Notes: HFLE: Hypertension-free life expectancy; LEwUofHTN = LE with unawareness of hypertension; LEwAofHTNnoTreat = LE with awareness 
of hypertension but no treatment; LEwCHTN = LE with controlled hypertension; LEwUHTN = LE with uncontrolled hypertension.
4 Discussion
This study has two main findings. First, compared with men, women have all types of 
HTN in significantly higher percentages across age groups and the prevalence of HTN 
increases as age increases for both men and women. In the 35–39 age group, 18% of 
women and 10% of men have HTN. In the 65–69 age group, the prevalence of HTN 
is 55% for women and 31% for men. Other studies for Bangladesh have also found 
HTN to be higher among women and the older population (Saquib, Saquib, Ahmed 
et al., 2012; Tareque, Koshio, Tiedt et al., 2015). Our study, furthermore, reveals that 
around half of respondents are unaware of HTN, and that among those with HTN, 
one-fourth of women and one-fifth of men have uncontrolled HTN. The prevalence of 
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uncontrolled HTN is higher among women than men, and it is higher among older than 
younger individuals. As HTN is a risk factor for developing coronary heart disease, 
stroke, and kidney disease, early detection and preventive behavior for HTN can 
reduce the risk of developing those non-communicable diseases. The high prevalence 
of unawareness of HTN and uncontrolled HTN in the current study suggests that 
a substantial number of cardiovascular events could be prevented in Bangladesh if 
proper steps were taken. This study thus suggests that women and older individuals, 
in particular, and all Bangladeshi individuals, in general, take appropriate measures to 
prevent and control HTN.
Second, compared with men, women have longer LE but they could expect shorter 
HFLE at all ages in terms of both number and proportion of years. As with women 
elsewhere around the world, Bangladeshi women can expect to live longer than men 
(Barford, Dorling, Smith et al., 2006; Tareque, Begum, and Saito, 2013; Tareque, 
Saito, and Kawahara, 2015). While various methods and measures have been used to 
measure health expectancy, none have computed HFLE, which makes it difficult to 
compare our findings with others. Studies on health expectancy in terms of disability 
in several countries have shown that women expect longer life than men with and 
without disability (Camargos, Machado, and do Nascimento Rodrigues, 2007; 
Jitapunkul, Kunanusont, Phoolcharoen et al., 2003), but women expect a greater 
proportion of their later years with a disability than do men (Camargos, Machado, and 
do Nascimento Rodrigues, 2007; Crimmins and Saito, 2001; Jitapunkul, Kunanusont, 
Phoolcharoen et al., 2003; Reyes-Beaman, Jagger, Garcia-Peña et al., 2005). However, 
a study on health expectancy in terms of disability for Bangladesh (Tareque, Begum, 
and Saito, 2013) used similar methods to our study and reported an exception. Despite 
having longer LE, elderly women could expect shorter disability-free life expectancy 
at all ages in both number and proportion of years compared with elderly men. This is 
in line with our findings. A different LE method than that used in our study was applied 
to calculate LE for normotensive and hypertensive Japanese people and found that the 
LE difference between normotensive and hypertensive individuals was 2.2 years for 
men and 2.9 years for women. The LE of 40-year-old Japanese men and women was 
41.7 years and 48.7 years, respectively, in normotensive participants and 39.5 and 45.8 
years, respectively, in hypertensive participants (Turin, Murakami, Miura et al., 2012).
For both men and women, the proportion of life with HTN increases as age increases. 
Compared with men, women could expect much longer proportion of LE with HTN as 
well as LE with all types of HTN at each age. The proportion of LE with HTN as well 
as LE with all types of HTN increases as age increases for both men and women, and 
the proportion of LE with HTN as well as LE with all types of HTN for men at age 65 
is lower than the respective proportion for women at age 35. The higher prevalence of 
HTN as well as all types of HTN for women and older individuals in Bangladesh is 
the reason behind the higher proportion of LE with HTN as well as LE with all types 
of HTN for women and older individuals in Bangladesh. The possibility of women 
developing HTN increases as they grow older, and in turn, more women become 
hypertensive compared to men. A significant amount of HTN in women is attributable 
to obesity (Chiang, Perlman, and Epstein, 1969), oral contraceptive use (American 
Heart Association, 2017; August and Oparil, 1999), preeclampsia and menopause 
(American Heart Association, 2017). Gender differences in functional status, HTN and 
health problems could be due to gender inequalities in nutritional status, marital status 
and education (Onadja, Atchessi, Soura et al., 2013), greater female longevity, and 
exposures to domestic violence (Guedes, Vafaei, Alvarado et al., 2016; Islam, Tareque, 
Tiedt et al., 2014). Higher prevalence of HTN among women could also be due to less 
than adequate care and services for pregnant/delivering mothers, and the impact of 
gender-related life conditions. Mothers encounter some long lasting health problems 
during the reproductive period, and the problems remain undisclosed due to cultural 
reasons. These health problems can cause women to fall sick with greater frequency 
during reproductive years as well as in later life (Tareque, Begum, and Saito, 2014). 
Patriarchy is also thought to limit women’s advancement, rights, and a cause of lower 
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status of women in Bangladesh. It could deprive women of many necessities including 
food, nutrition, health care, secure life, a respectable living, mental peace, and an 
abuse-free life (Tareque, Begum, and Saito, 2014). Consequently, compared to men, 
women could have more health problems as well as HTN. Therefore, to effectively 
detect, prevent, and control HTN, especially unawareness of HTN and uncontrolled 
HTN, older people, and women in particular, should receive special attention. This will 
help to increase HFLE and quality of life.
The Sullivan method has several advantages. As a prevalence-based method it is 
straightforward to apply on data from cross-sectional studies, which are less costly and 
more readily available than longitudinal studies. It is less influenced by survey design 
and analytic strategies than methods relying on longitudinal data. The Sullivan method 
has some limitations as well. The method’s assumptions constrain the portrayal of the 
expected life cycle or functional status histories of persons who are exposed to current 
mortality and morbidity conditions. It does not permit recovery, once individuals 
have experienced a health problem. It will yield an inaccurate portrayal of the timing 
and volume of a cohort’s health experiences under conditions in which individuals 
experience both the onset of health problems and recovery (Robine, Jagger, Mathers 
et al., 2003). Although the Sullivan method could not detect a sudden change in health 
problems, it provides fairly stable estimates as multistate life table method if there are 
smooth and relatively regular changes in health problems prevalence rates over long 
times (Mathers and Robine, 1997).
5 Conclusions
The most recent and reliable nationally representative data sets from the 2011 BDHS 
provided insights into gender differences in HFLE and the size of the population at 
risk for HTN, unawareness of HTN, and uncontrolled HTN among the Bangladeshi 
people. To prevent and control HTN and to increase HFLE and quality of life, attention 
should be given to women and older adults. The findings of this study shed important 
light on the risk of disease and the lowering of quality of life associated with HTN in 
Bangladesh. The knowledge that HTN among the Bangladeshi people, particularly 
Bangladeshi women, may be the result of a number of past life-time experiences 
related to education, health care, physical inactivity, life styles, unhealthy food habits, 
etc., can serve as a guide for public policies in the country. Further work is needed 
to determine the correlates of HTN, unawareness of HTN, and uncontrolled HTN 
in Bangladesh to help policy makers and planners formulate appropriate policies 
regarding HTN.
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